PARTNERSHIPS FOR GLOBAL SURGERY · RESEARCH PROPOSAL
[ Descriptive Project Title]
ONE-SENTENCE PITCH I want to [do what] using [what data, setting or literature] to answer [question], over [X] months.
PRESENTED BY
[Name]
HOME INSTITUTION
[School or program]
COLLABORATORS & SITE
[Name, role, institution, country]
DATE
[DD Month YYYY]
How to use this template
Read this once, fill in every bracket, then delete this slide. Speaker notes have helpful info
DELETE ME
BEFORE YOU BUILD
TIMING
HOW TO SPEAK TO IT
THE ONE THING THIS PRESENTATION IS FOR
Can this be done, by you (with help), with that data, in that time, for that money?
IT WORKS FOR ANY STUDY TYPE
Chart review or cohort · secondary analysis of existing data · systematic or scoping review · survey · qualitative · before-after or randomised comparison · quality improvement. Where a box genuinely does not apply, write "n/a" and say why.
The PICOTT question
Population · Intervention · Comparator · Outcome · Time · Type of study.
P: POPULATION
[Who, where, what age, what condition, what setting or dataset.]
I: INTERVENTION OR EXPOSURE
[What is done, given, or experienced. For observational work, this is the exposure.]
C: COMPARATOR
[Another group, another period, before vs after, or "none, descriptive".]
O: OUTCOME
[The one thing you will measure, defined so a stranger could collect it.]
T: TIME
[Follow-up duration, or the period the data covers.]
T: TYPE OF STUDY
[The design in a few words: chart review, cohort, survey, scoping review, before-after, randomised. Detail on the Study design slide.]
PRIMARY OBJECTIVE
To [verb] the [outcome] among [population] using [data or setting], over [period].
SECONDARY AIM (ONE AT MOST)
[ ] or "none"
Background and the gap
WHY THIS PROBLEM MATTERS
WHAT IS ALREADY KNOWN
THE GAP, IN ONE SENTENCE
"No study has [done what] for [which population or setting]."
[Why that gap matters]
WHOSE PRIORITY THIS IS
[Who called this a priority: a clinician at the site, a ministry, a national plan.]
[If the idea is yours, say so, and how you will check it matters locally.]
Appendix B holds your feasibility self-check and a table of what the prior studies found.
Study design
Name the design, say why it fits, and pick its reporting checklist now.
STUDY TYPE, AND WHY IT FITS
Type: [name it plainly: retrospective chart review, cross-sectional survey, before-after study, randomised comparison (non-clinical), scoping review, burden-of-disease analysis…]
[It can show [what]]
[Why this design]
CHECKLIST, ETHICS AND REGISTRATION
Report to: [STROBE / CONSORT 2025 / PRISMA 2020 / GATHER / COREQ / other. See Appendix A]
Ethics: [IRB or local ethics committee approval, or documented waiver] · Consent: [written / verbal / waiver, in what language]
Register only if applicable: [review → PROSPERO, OSF or JBI · prospective study → ClinicalTrials.gov · otherwise not customary]
If randomising: [what is randomised, how, and who measures the outcome]
Data and analysis
WHERE THE DATA COMES FROM, AND WHO IS INCLUDED
HOW MUCH DATA I EXPECT, AND HOW I KNOW
HOW IT GETS COLLECTED
HOW IT GETS ANALYSED
Write the data dictionary and pick the analysis before collecting anything.
Timeline
Shade the months each phase is active. Phases can overlap.
Month 1 = [Month YYYY] Total length: [n] months
Phase | Done when… | Owner | M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | M11 | M12 |
Protocol & data dictionary | Protocol final; every variable defined; registered if applicable | [ ] | | | | | | | | | | | | |
Ethics & approvals | Approval letter or exempt determination in hand | [ ] | | | | | | | | | | | | |
Set-up & training | Form built and piloted on [n] records; collectors trained | [ ] | | | | | | | | | | | | |
Data collection | [n] records reached; completeness checked [how often] | [ ] | | | | | | | | | | | | |
Analysis | Dataset locked; pre-specified analysis run | [ ] | | | | | | | | | | | | |
Write-up & sharing back | Draft done; results shared with [whom] | [ ] | | | | | | | | | | | | |
Find the ethics committee’s real meeting dates before shading that row.
Team
Who does what, and how much of it. Tasks follow the ICMJE criteria, so authorship is clear later.
TEAM SIZE
[n] people · about [n] hours of other people’s time
[How I estimated it, e.g. 300 records ÷ 10 per hour = 30 hours.]
ROLES I STILL NEED FILLED
[Which role, and what I need to fill it.]
Task / role (ICMJE criterion) | How many needed | Name(s) | Est. hours |
Conception & design (1) | [n] | [Your name] | [ ] |
Ethics submission & approvals (1) | [n] | [ ] | [ ] |
Data acquisition / collection (1) | [n] | [ ] | [ ] |
Analysis & interpretation (1) | [n] | [ ] | [ ] |
Drafting the manuscript (2) | [n] | [ ] | [ ] |
Critical revision & final approval (2, 3) | [n] | [ ] | [ ] |
Support roles, not authorship (translation, coordination, data entry) | [n] | [ ] | [ ] |
ICMJE authorship needs all four: (1) substantial contribution to conception, design, acquisition, analysis or interpretation; (2) drafting or critically revising it; (3) approving the final version; (4) accountability for the work. A blank name is a gap — say so on the next slide.
What help I need
Tick the two or three you actually need, and write what exactly. Blanks say the rest is covered.
WHAT I NEED HELP WITH
Ethics & approvals
[what exactly, from whom, and by when]
Data access
[what exactly, from whom, and by when]
Statistics
[what exactly, from whom, and by when]
People for the work
[what exactly, from whom, and by when]
In-country & logistics
[what exactly, from whom, and by when]
Funding
[what exactly, from whom, and by when]
Mentorship & oversight
[what exactly, from whom, and by when]
Writing & publication
[what exactly, from whom, and by when]
Appendix A: design families and checklists
Not presented. Find your design here if you are unsure what it is called.
DELETE ME AFTER DECIDING
Design | Report to | Register? |
Cohort, case-control, cross-sectional | STROBE | Encouraged if prospective, not required |
Chart review, registry or routine data | RECORD | Not customary — IRB or waiver instead |
Before-after or non-randomised comparison | TREND | Required if you assign the intervention |
Randomised comparison | CONSORT 2025 | Required, before the first consent |
Burden of disease estimates | GATHER | Not customary |
Diagnostic or screening accuracy | STARD 2015 | Encouraged if prospective |
Prediction model | TRIPOD+AI | Encouraged; OSF is the usual place |
Instrument validation or translation | COSMIN | Not customary |
Systematic review, meta-analysis | PRISMA 2020 | PROSPERO, before screening starts |
Scoping review | PRISMA-ScR | OSF — PROSPERO does not take these |
Qualitative | COREQ or SRQR | Not customary |
Consensus or Delphi | ACCORD | Not customary |
Survey | CROSS · CHERRIES for web | Not customary |
Quality improvement | SQUIRE 2.0 | Not customary |
Implementation study | StaRI | Required if an intervention is assigned |
Economic evaluation | CHEERS 2022 | Follows the study it sits on |
Case report or series | CARE | No registry — consent; IRB if >3 cases |
THREE THINGS PEOPLE ASK
Report to = the checklist your finished paper must satisfy. EQUATOR keeps them all.
Ethics comes first, and is separate. Almost every study needs IRB or local ethics committee approval, or a documented waiver; primary data collection normally needs participant consent.
Register = required only when you prospectively assign people to an intervention (ICMJE), in ClinicalTrials.gov or a WHO primary registry such as PACTR or CTRI, before the first consent. Reviews register in PROSPERO. Observational work is encouraged, not required.
WHERE TO FIND THEM
clinicaltrials.gov
who.int/clinical-trials-registry-platform
Appendix B: before the meeting, and later
Not presented. Prep work: the feasibility self-check, and what the prior studies already show.
DELETE ME AFTER DECIDING
FEASIBILITY SELF-CHECK
The data exists and I can reach it
CONFIRMED · PARTLY · UNKNOWN
The people I need have said yes
CONFIRMED · PARTLY · UNKNOWN
I have the time
CONFIRMED · PARTLY · UNKNOWN
Skills covered, incl. statistics
CONFIRMED · PARTLY · UNKNOWN
Approvals are achievable
CONFIRMED · PARTLY · UNKNOWN
The cost is within reach
CONFIRMED · PARTLY · UNKNOWN
WHAT THE PRIOR STUDIES FOUND (FROM YOUR SCOPING SEARCH)
Study (author, year) | Design, setting, n | Key finding | Gap it leaves |
[ ] | [ ] | [ ] | [ ] |
[ ] | [ ] | [ ] | [ ] |
[ ] | [ ] | [ ] | [ ] |
[ ] | [ ] | [ ] | [ ] |
[ ] | [ ] | [ ] | [ ] |
THE GAP THIS PROJECT FILLS
[One sentence: what none of the studies above did. It should match the gap sentence on the Background slide.]